Prospects for the treatment of drug-resistant malaria parasites. (Q36895758)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

2 references

18 July 2021

Prospects for the treatment of drug-resistant malaria parasites (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

18 July 2021

Plasmodium falciparum

1 reference

18 July 2021

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Timothy M Davis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Patrick G Bray

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 June 2006

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

18 July 2021

15

1 reference

inferred from page(s)

published in

Future Microbiology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

18 July 2021

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

127-141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17661691%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

2 January 2020

copyright license

1 reference

18 July 2021

0 references

The global distribution of clinical episodes of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Malaria risk: estimation of the malaria burden

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Should chloroquine be laid to rest?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Malaria: to kill a parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Medical need, scientific opportunity and the drive for antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

21 January 2018

Winning the drugs war.

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Falciparum malaria: current therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Theories on malarial pigment formation and quinoline action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Structure-function relationships in chloroquine and related 4-aminoquinoline antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Chloroquine-resistant Plasmodium falciparum: effect of substrate on chloroquine and amodiaquin accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Uptake of [3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The principal chloroquine resistance protein of Plasmodium falciparum is a member of the drug/metabolite transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Treatment of uncomplicated falciparum malaria in southern Vietnam: can chloroquine or sulfadoxine-pyrimethamine be reintroduced in combination with artesunate?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Genetic and biochemical aspects of drug resistance in malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Spread of chloroquine resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The role of drug accumulation in 4-aminoquinoline antimalarial potency. The influence of structural substitution and physicochemical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Transporter of a malaria catastrophe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Antimalarial Drug Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Piperaquine: a resurgent antimalarial drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Control of heme polymerase by chloroquine and other quinoline derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Quinoline antimalarials decrease the rate of beta-hematin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Epidemiology of drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Definitive proof for a role of pfmdr 1 in quinoline resistance in Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Contribution of the pfmdr1 gene to antimalarial drug-resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Reversal of chloroquine resistance in Plasmodium falciparum by verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Antimalarial combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinin and derivatives: the future for malaria treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Qinghaosu (artemisinin): an antimalarial drug from China

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinin: mechanisms of action, resistance and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Radical mechanism of action of the artemisinin-type compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Possible modes of action of the artemisinin-type compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

An Over Four Millennium Story Behind Qinghaosu (Artemisinin)-A Fantastic Antimalarial Drug from a Traditional Chinese Herb

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The interaction of artemisinin with malarial hemozoin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinin, an Endoperoxide Antimalarial, Disrupts the Hemoglobin Catabolism and Heme Detoxification Systems in Malarial Parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinins: activities and actions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinins target the SERCA of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

A single amino acid residue can determine the sensitivity of SERCAs to artemisinins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Yeast model uncovers dual roles of mitochondria in action of artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Antimalarial drug resistance and combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Coartem (artemether-lumefantrine) in Africa: the beginning of the end?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Antimalarial treatment with artemisinin combination therapy in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artesunate combinations for treatment of malaria: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

WHO, the Global Fund, and medical malpractice in malaria treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The benefits of artemisinin combination therapy for malaria extend beyond the individual patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemether-lumefantrine for uncomplicated malaria: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Drug combinations for malaria: time to ACT?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Pitfalls in estimating piperaquine elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Engineering a mevalonate pathway in Escherichia coli for production of terpenoids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinin-based combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Artemisone--a highly active antimalarial drug of the artemisinin class

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Identification of an antimalarial synthetic trioxolane drug development candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Antimalarial activity of a synthetic endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum isolates from Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Fosmidomycin, a novel chemotherapeutic agent for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

The "roll back malaria" campaign

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Lysosomes and drug resistance in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

Chloroquine resistance in Plasmodium vivax

21 January 2018

2 references

https://api.crossref.org/works/10.2217%2F17460913.1.1.127

21 January 2018

12 December 2020

Morphologic effects of artemisinin in Plasmodium falciparum

1 reference

12 December 2020

Correlation of antimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrin IX

1 reference

12 December 2020

Access to hematin: the basis of chloroquine resistance.

1 reference

12 December 2020

Further Evidence Supporting the Importance of and the Restrictions on a Carbon-Centered Radical for High Antimalarial Activity of 1,2,4-Trioxanes Like Artemisinin

1 reference

12 December 2020

Mefloquine - its 20 years in the Thai Malaria Control Program

1 reference

12 December 2020

Antimalaria studies on Qinghaosu

1 reference

12 December 2020

The public health impact of chloroquine resistance in Africa

1 reference

12 December 2020

Evidence for a Central Role for PfCRT in Conferring Plasmodium falciparum Resistance to Diverse Antimalarial Agents

1 reference

12 December 2020

Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria

1 reference

12 December 2020

Averting a malaria disaster in Africa--where does the buck stop?

1 reference

12 December 2020

Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices

1 reference

12 December 2020

Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria

1 reference

12 December 2020

Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

1 reference

12 December 2020

Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine.

1 reference

12 December 2020

Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro.

1 reference

12 December 2020

The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress

1 reference

12 December 2020

The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: Chemical mechanisms and the effects of fluorine substitution

1 reference

12 December 2020

Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis.

1 reference

12 December 2020

In vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum

1 reference

12 December 2020

Artemisinin-based combination therapies for uncomplicated malaria

1 reference

12 December 2020